Condition: Suspected Asthma · Sponsor: AstraZeneca
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multi-center study to explore the positive predictive value of bronchodilation test with portable oscillometry compared to either BDT or BPT with spirometry in asthma diagnosis and to compare it with bronchodilation with spirometry (the current gold standard). In the study, the target patients' profile is the suspected asthma patient with asthmatic symptoms (wheezing, shortness of breath, chest tightness, and/or cough) and aim to enroll 500 participants from 25 sites across different regions in China.
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Beijing, China | Recruiting |
| Research Site | Cangzhou, China | Not Yet Recruiting |
| Research Site | Changsha, China | Not Yet Recruiting |
| Research Site | Changsha, China | Not Yet Recruiting |
| Research Site | Chengdu, China | Not Yet Recruiting |
| Research Site | Chongqing, China | Not Yet Recruiting |
| Research Site | Guangzhou, China | Not Yet Recruiting |
| Research Site | Guangzhou, China | Not Yet Recruiting |
| Research Site | Guangzhou, China | Not Yet Recruiting |
| Research Site | Kunming, China | Not Yet Recruiting |
| Research Site | Quanzhou, China | Not Yet Recruiting |
| Research Site | Shanghai, China | Not Yet Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.